Subscribe

0

‪‪Sun Pharmaceutical‬

Sun Pharma Reported a Consolidated Loss of Rs 2227.38 Cr in Q4 of FY22 Sectors

Sun Pharma Reported a Consolidated Loss of Rs 2227.38 Cr in Q4 of FY22

The company's exceptional items for the fourth quarter of 2021-22 stood at Rs 3,935.75 crore against Rs 672.81 crore in the corresponding quarter of 2020-21. Exceptional items include settlements, and provisions related to Taro Pharmaceuticals, and Ranbaxy.

By SMEStreet Edit Desk
May 31, 2022 04:29 IST 1 Min read
RITES, Sun Pharmaceutical, Strides Pharma are Among Top Attractions at SENSEX & NIFTY Stock Market News
RITES, Sun Pharmaceutical, Strides Pharma are Among Top Attractions at SENSEX & NIFTY
By SMEStreet Desk
Sep 19, 2018 05:17 IST 2 Min read
Sun Pharma Gets Form 483 from US FDA to Sun Pharma's Halol facility in Gujarat InFocus
Sun Pharma Gets Form 483 from US FDA to Sun Pharma's Halol facility in Gujarat
By SMEStreet Edit Desk
Feb 23, 2018 12:19 IST 3 Min read